[
    [
        {
            "time": "",
            "original_text": "两年飙涨8倍，美迪西怎么变成CXO黑马",
            "features": {
                "keywords": [
                    "美迪西",
                    "CXO",
                    "飙涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "两年飙涨8倍，美迪西怎么变成CXO黑马",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报：如何看待生物试剂未来空间？",
            "features": {
                "keywords": [
                    "医药",
                    "生物试剂",
                    "未来空间"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药行业周报：如何看待生物试剂未来空间？",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【2359】药明康德中期纯利增55.8% 不派息 | 头条金融网",
            "features": {
                "keywords": [
                    "药明康德",
                    "纯利增",
                    "55.8%",
                    "不派息"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【2359】药明康德中期纯利增55.8% 不派息 | 头条金融网",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-02",
            "original_text": "【兴业证券医药】新冠药物研发分析 - 医药行业周报(2021.08.02-2021.08.06)",
            "features": {
                "keywords": [
                    "新冠药物",
                    "研发分析",
                    "医药行业"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "新冠"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【兴业证券医药】新冠药物研发分析 - 医药行业周报(2021.08.02-2021.08.06)",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "【行情】港股药品股与生物科技股走低，复星医药跌超6%，康方生物、君实生物、康希诺生物均跌超4%，药明康德与再鼎医药跌超2%",
            "features": {
                "keywords": [
                    "港股",
                    "药品股",
                    "生物科技股",
                    "复星医药",
                    "康方生物",
                    "君实生物",
                    "康希诺生物",
                    "药明康德",
                    "再鼎医药",
                    "跌超"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【行情】港股药品股与生物科技股走低，复星医药跌超6%，康方生物、君实生物、康希诺生物均跌超4%，药明康德与再鼎医药跌超2%",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "顶流隐形重仓股曝光！谢治宇、葛兰、归凯买了啥？",
            "features": {
                "keywords": [
                    "顶流",
                    "隐形重仓股",
                    "谢治宇",
                    "葛兰",
                    "归凯"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "顶流隐形重仓股曝光！谢治宇、葛兰、归凯买了啥？",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]